Menis J, Twelves C. Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer. Breast Cancer (London). 2011;3:101–111.
Professor Twelves has received honoraria from Eisai.
. 2011 Dec 30;4:1. doi: 10.2147/BCTT.S26170
Corrigendum
Collection date 2012.
© 2012 Menis et al, publisher and licensee Dove Medical Press Ltd
This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
PMCID: PMC3846749 PMID: 24367187
This corrects the article "Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer" in volume 3 on page 101.